Paclitaxel

Records for this ingredient, by country (identity only).

ATC L01CD01 · 13 markets · 403 records

Paclitaxel 13 markets · 403 records Forms
Filters
MarketCN 89GB 85AU 70US 41HK 16SG 14ES 11FR 11CA 8TW 8JP 5MX 4EU 4

CN 89 records · 10 shown of 10 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 30 mg/5 mLinjection安素泰紫杉醇泰素、特素、紫素、辰易、Manufacturer: 上海上药新亚药业有限公司、Manufacturer: 上海创诺制药有限公司、Manufacturer: 云南植物药业有限公司、Manufacturer: 亚宝药业集团股份有限公司 +25 also in GB·AU·SG
    +2Other 2 marketsTWJP
  • 100 mg per mL / per unit basis not statedinjectionABRAXANE紫杉醇Manufacturer: CelgeneCorporation、Manufacturer: 正大天晴药业集团股份有限公司、Manufacturer: 江苏康禾生物制药有限公司、Manufacturer: 江苏恒瑞医药股份有限公司、Manufacturer: 河北道恩药业有限公司、Manufacturer: 浙江海昶生物医药技术有限公司、Manufacturer: 浙江海正药业股份有限公司、Manufacturer: 湖南科伦制药有限公司 +2
  • 100 mg/16.7 mLinjection特素紫杉醇辰易、Manufacturer: 四川汇宇制药股份有限公司、Manufacturer: 扬子江药业集团有限公司、Manufacturer: 无锡紫杉药业股份有限公司、Manufacturer: 海南全星制药有限公司、Manufacturer: 海南卓泰制药有限公司、Manufacturer: 海南新世通制药有限公司、Manufacturer: 海南通用康力制药有限公司 also in GB·SG·JP
  • 60 mg/10 mLinjection辰易紫杉醇Manufacturer: 北京华素制药股份有限公司、Manufacturer: 北京协和药厂、Manufacturer: 吉斯美(武汉)制药有限公司、Manufacturer: 哈尔滨三联药业股份有限公司、Manufacturer: 海南卓泰制药有限公司、Manufacturer: 海口市制药厂有限公司、Manufacturer: 深圳万乐药业有限公司
  • 150 mg/25 mLinjection安素泰紫杉醇Manufacturer: 海南卓泰制药有限公司 also in GB·AU
  • 30 mg per mL / per unit basis not statedinjectionManufacturer: 上海谊众药业股份有限公司
  • 300 mg/30 mLliquidManufacturer: DAEHWAPHARMACEUTICALCO.,LTD.
  • 25 mL per mL / per unit basis not statedinjectionManufacturer: 江苏奥赛康药业有限公司 ×4
  • 16.7 mL per mL / per unit basis not statedinjectionManufacturer: 江苏奥赛康药业有限公司 ×4
  • 10 mL per mL / per unit basis not statedinjectionManufacturer: 江苏奥赛康药业有限公司 ×4

GB 85 records · 12 shown of 43 Source NHSBSA dm+d · Data as of 2026-10-19

Other strengths: 31 · 1 dosage forms Otras concentraciones: 31 · 1 formas farmacéuticas 其余规格 31 个 · 涉及 1 种剂型 其餘規格 31 個 · 涉及 1 種劑型 · 336 mg/500 mL、300 mg/500 mL、270 mg/500 mL、240 mg/500 mL、216 mg/500 mL、198 mg/500 mL、180 mg/500 mL、180 mg/250 mL、162 mg/500 mL、162 mg/250 mL、144 mg/250 mL、132 mg/250 mL、120 mg/250 mL、108 mg/250 mL、96 mg/250 mL、90 mg/100 mL、90 mg/250 mL、84 mg/100 mL、84 mg/250 mL、78 mg/100 mL、72 mg/100 mL、66 mg/100 mL、60 mg/100 mL、54 mg/100 mL、49.2 mg/100 mL、44.4 mg/100 mL、39.6 mg/100 mL、36 mg/50 mL、32.4 mg/50 mL、28.8 mg/50 mL
injection · 31336 mg/500 mL300 mg/500 mL270 mg/500 mL240 mg/500 mL216 mg/500 mL198 mg/500 mL180 mg/500 mL180 mg/250 mL162 mg/500 mL162 mg/250 mL This form has 21 more Esta forma tiene 21 más 该剂型还有 21 个 該劑型還有 21 個

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

AU 70 records · 10 shown of 10 Source ARTG index enrichment (TGA eBS cur、TGA +2 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 30 mg/5 mLinjectionANZATAX 150mg/25mL injection vial also in CN·GB·SG
    +2Other 2 marketsTWJP
  • 100 mg per mL / per unit basis not statedinjectionABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vialCIPLA PACLITAXEL Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial、HOSPIRA US PACLITAXEL INJECTION 300mg/50mL vial.、NAB-PACLITAXEL ACCORD paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection vial、NAB-PACLITAXEL INTAS paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection vial、Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial、NANOPACLICIP Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial、PACLIALL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial、PACLITAXEL ACCORD paclitaxel 100 mg/16.7 mL concentrated injection vial +3 unknown
  • 6 mg/mL per mL / per unit basis not statedinjectionANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAINANZATAX paclitaxel 100mg/16.7mL injection vial、Hospira ANZATAX (Paclitaxel) Injection 30 mg/ 5 mL vial、Hospira Anzatax (Paclitaxel) Injection Concentrate 30 mg/5 mL Vial、Hospira ANZATAX Paclitaxel 300 mg/50 mL Injection vial - Asia、Hospira Paclitaxel 150 mg/25 mL (6 mg/mL) Concentrate for Injection Vial、Hospira Paclitaxel 6 mg/mL Concentrated Solution for Infusion, 30 mg/5 mL Vial、Hospira Paclitaxel Concentrate for Solution for Infusion 30 mg/5 mL Vial、Hospira Paclitaxel concentrate for solution for infusion, 300 mg/50 mL Oncotain +7 unknown
  • 6 mg per mL / per unit basis not statedinjectionHospira ANZATAX (Paclitaxel) Injection 30 mg/ 5 mL vial unknown
  • 300 mg/50 mLinjectionPACLITAXEL ACCORDPaclitaxel Ebewe also in GB·SG
  • 300 mg per mL / per unit basis not statedinjectionANZATAX injection concentrate paclitaxel 150mg/25mL multidose vialHOSPIRA US PACLITAXEL INJECTION 300mg/50mL vial.、PACLITAXEL ACC paclitaxel 300 mg/50 mL concentrated injection vial、PACLITAXEL ACCORD paclitaxel 100 mg/16.7 mL concentrated injection vial、PACLITAXEL EBEWE paclitaxel 30 mg/5 mL concentrated injection vial、PACLITAXEL INTAS paclitaxel 30 mg/5 mL concentrated injection vial unknown
  • 150 mg/25 mLinjectionANZATAX 150mg/25mL injection vial also in CN·GB
  • 30 mg per mL / per unit basis not statedinjectionHOSPIRA US PACLITAXEL INJECTION 300mg/50mL vial.PACLITAXEL ACCORD paclitaxel 100 mg/16.7 mL concentrated injection vial、PACLITAXEL EBEWE paclitaxel 30 mg/5 mL concentrated injection vial、PACLITAXEL INTAS paclitaxel 30 mg/5 mL concentrated injection vial unknown
  • 150 mg per mL / per unit basis not statedinjectionANZATAX injection concentrate paclitaxel 150mg/25mL multidose vialPACLITAXEL EBEWE paclitaxel 30 mg/5 mL concentrated injection vial unknown
  • 250 mg per mL / per unit basis not statedinjectionABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial unknown
6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ABRAXANE ×2Anzatax Injection ×1nab-Paclitaxel Accord ×1nab-PACLITAXEL JUNO ×2PACLITAXEL ACCORD ×2Paclitaxel Ebewe ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 41 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

  • 6 mg per mL / per unit basis not statedinjectionPACLITAXEL PACLITAXELManufacturer: Alembic Pharmaceuticals Inc.、Manufacturer: Alembic Pharmaceuticals Lim…、Manufacturer: BluePoint Laboratories、Manufacturer: Bryant Ranch Prepack、Manufacturer: Fresenius Kabi USA, LLC、Manufacturer: Hospira, Inc.、Manufacturer: Natco Pharma USA LLC、Manufacturer: Northstar Rx LLC +3
  • 100 mg/20 mLinjectionABRAXANEPaclitaxel 100mg per vial、PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND、Paclitaxel protein-bound particles for injectable suspension (albumin-bound)、Manufacturer: Cipla USA Inc.、Manufacturer: Mylan Institutional LLC、Manufacturer: Sandoz Inc、Manufacturer: Teva Pharmaceuticals, Inc.
  • 100 mg/100 mginjectionPaclitaxel

HK 16 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

16 records · 0 manufacturers 16 registros · 0 fabricantes 16 个记录 · 0 个厂家 16 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ABRAXANE FOR INJECTABLE ×3ANZATAX INJ 30MG/5ML VIAL ×1EBETAXEL INJ 6MG/ML ×1PACLITAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/16.7ML ×9PACLITAXEL CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/16.7ML ×4PACLITAXEL USP ×2PACLITAXEL-TEVA CONCENTRATE FOR SOLN FOR INFUSION 6MG/ML ×1PAXEL CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/16.7ML ×9

and 3 more (0 manufacturers) y 3 más (0 fabricantes) 还有 3 个（0 个厂家） 還有 3 個（0 個廠商）

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 14 records · 6 shown of 6 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 30 mg/5 mLinjectionANZATAX INJECTION CONCENTRATE 6 mg/mlPACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML also in CN·GB·AU
    +2Other 2 marketsTWJP
  • 6 mg/mL per mL / per unit basis not statedinjectionCYTAX PACLITAXEL INJECTION USP CONCENTRATE 6 MG/ MLEBETAXEL INJECTION 6MG/ML、FONKOPAC CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML、GENEXOL INJECTION 6 mg/ml、INTAXEL INJECTION 6 mg/ml、PACLITAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML、PACLITAXEL INJECTION 6 MG/ML、PAXEL INJECTION 6 mg/ml
  • 6 mg per mL / per unit basis not statedinjectionAclipak Concentrate for Solution for Infusion 6mg/ ml
  • 100 mg/16.7 mLinjectionPACLITERO 100 SOLUTION FOR INJECTION 100MG/16.7ML also in CN·GB·JP
  • 300 mg/50 mLinjectionPACLITERO 300 SOLUTION FOR INJECTION 300MG/50ML also in GB·AU
  • 100 mg/vial per mL / per unit basis not statedinjectionABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial

ES 11 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

  • 100 mg per mL / per unit basis not statedinjectionABRAXANE
  • 6 mg/1 mLinjectionPACLITAXEL ACCORDPACLITAXEL AUROVITAS、PACLITAXEL HOSPIRA、PACLITAXEL KABI、PACLITAXEL TEVA also in FR
  • 5 mg/1 mLinjectionAPEXELSINBUGVI、NAVERUCLIF、PACLITAXEL ALBUMINA REDDYS、PAZENIR

FR 11 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

  • 100 mg per mL / per unit basis not statedinjectionABRAXANE 5 mg/mL, poudre pour dispersion injectable pour perfusionBUGVI 5 mg/mL, poudre pour dispersion pour perfusion、NAVERUCLIF 5 mg/mL, poudre pour dispersion pour perfusion、PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
  • 6 mg/1 mLinjectionPACLITAXEL AHCL 6 mg/ml, solution à diluer pour perfusionPACLITAXEL ARROW 6 mg/ml, solution à diluer pour perfusion、PACLITAXEL HOSPIRA 6 mg/mL, solution à diluer pour perfusion、PACLITAXEL KABI 6 mg/ml, solution à diluer pour perfusion、PACLITAXEL TEVA 6 mg/mL, solution à diluer pour perfusion、PACLITAXELSANDOZ 6 mg/ml, solution à diluer pour perfusion also in ES
  • 100 mg/50 mLinjectionAPEXELSIN 5 mg/mL, poudre pour dispersion pour perfusion

CA 8 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 6 mg per mL / per unit basis not statedliquidPaclitaxelPACLITAXEL USP
  • 100 mgpowderABRAXANE FOR INJECTABLEPACLITAXEL FOR INJECTABLE NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL

TW 8 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

  • 30 mg/5 mLinjectionTAXOL (PACLITAXEL) INJECTION 30MG/5ML汰癌勝注射液（派立達師） also in CN·GB·AU
    +2Other 2 marketsSGJP
  • 6 mg per mL / per unit basis not statedinjection"政德" 淨癌順注射液６毫克/毫升"杏輝" 輝克癒蘇注射劑６毫克/毫升、GENAXOL INJECTION 6MG/ML "GENTLE"、GENETAXYL CREM LESS INJECTION 6MG/ML (PACLITAXEL)、Paclitero (Paclitaxel Injection 6mg/ml)、PHYXOL INJECTION 6MG/ML "SINPHAR"、克抑癌注射液、欣沛方注射液 6 毫克/毫升
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名"永信" 伏摩素注射液 ×1ABRAXANE FOR INJECTABLE ×3FORMOXOL INJECTION ×1Intaxel Injection ×1亞伯杉注射劑 ×1癌克平注射液 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 5 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

MX 4 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名AQUSpax ×1PACMIC ×1TAXZE ×1ZORVANTIX ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 4 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ABRAXANE ×2APEXELSIN ×2NAVERUCLIF ×2PAZENIR ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 紫杉酚 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.